Joseph T. Phan

Array ( [id] => 3701593 [patent_doc_number] => 05653977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-05 [patent_title] => 'Anti-idiotypic antibody that mimics the GD2 antigen' [patent_app_type] => 1 [patent_app_number] => 8/548378 [patent_app_country] => US [patent_app_date] => 1995-10-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6728 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/653/05653977.pdf [firstpage_image] =>[orig_patent_app_number] => 548378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3887456 [patent_doc_number] => 05834245 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'PRLTS proteins and DNA\'s encoding the same' [patent_app_type] => 1 [patent_app_number] => 8/506864 [patent_app_country] => US [patent_app_date] => 1995-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 8374 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834245.pdf [firstpage_image] =>[orig_patent_app_number] => 506864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4040956 [patent_doc_number] => 05874250 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-23 [patent_title] => 'DNA encoding for a protein containing the extracellular domain of lymphocyte activation gene 3' [patent_app_type] => 1 [patent_app_number] => 8/474988 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 11 [patent_no_of_words] => 10786 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/874/05874250.pdf [firstpage_image] =>[orig_patent_app_number] => 474988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3656577 [patent_doc_number] => 05656275 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-08-12 [patent_title] => 'Recombinant raccoon pox virus comprising the DNA encoding the nucleocapsid protein of feline infectious peritonitis virus' [patent_app_type] => 1 [patent_app_number] => 8/480882 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 30 [patent_no_of_words] => 6488 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/656/05656275.pdf [firstpage_image] =>[orig_patent_app_number] => 480882 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3759713 [patent_doc_number] => 05721339 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-24 [patent_title] => 'Gamma antigen of pathogenic group B streptococci' [patent_app_type] => 1 [patent_app_number] => 8/481582 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6519 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/721/05721339.pdf [firstpage_image] =>[orig_patent_app_number] => 481582 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3777905 [patent_doc_number] => 05820880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-13 [patent_title] => 'Liposomal formulation' [patent_app_type] => 1 [patent_app_number] => 8/480563 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 14 [patent_no_of_words] => 4444 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/820/05820880.pdf [firstpage_image] =>[orig_patent_app_number] => 480563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4021211 [patent_doc_number] => 05925526 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-07-20 [patent_title] => 'Antigen recognized by patients with antibody associated cerebellar degeneration, DNA encoding same and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/478609 [patent_app_country] => US [patent_app_date] => 1995-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7381 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/925/05925526.pdf [firstpage_image] =>[orig_patent_app_number] => 478609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4232666 [patent_doc_number] => 06090386 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-07-18 [patent_title] => 'T cell peptides of the CRX JII allergen' [patent_app_type] => 1 [patent_app_number] => 8/467023 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 59 [patent_figures_cnt] => 67 [patent_no_of_words] => 77295 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/090/06090386.pdf [firstpage_image] =>[orig_patent_app_number] => 467023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695564 [patent_doc_number] => 05679768 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-21 [patent_title] => 'Epitopic regions of pneumococcal surface protein A' [patent_app_type] => 1 [patent_app_number] => 8/465746 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6636 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/679/05679768.pdf [firstpage_image] =>[orig_patent_app_number] => 465746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790789 [patent_doc_number] => 05780289 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Coccidiosis poultry vaccine DNA encoding an elmeria 20K antigen' [patent_app_type] => 1 [patent_app_number] => 8/468855 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15373 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780289.pdf [firstpage_image] =>[orig_patent_app_number] => 468855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3726282 [patent_doc_number] => 05670362 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-23 [patent_title] => 'DNA encoding an Eimeria 100kD antigen' [patent_app_type] => 1 [patent_app_number] => 8/468853 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15451 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/670/05670362.pdf [firstpage_image] =>[orig_patent_app_number] => 468853 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858023 [patent_doc_number] => 05792644 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'DNA encoding an Eimeria 200 kd antigen' [patent_app_type] => 1 [patent_app_number] => 8/468852 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 15452 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792644.pdf [firstpage_image] =>[orig_patent_app_number] => 468852 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3855120 [patent_doc_number] => 05792457 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Antibody recognizing endothelial cell ligand for leukocyte CR3' [patent_app_type] => 1 [patent_app_number] => 8/465929 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 47 [patent_no_of_words] => 23368 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792457.pdf [firstpage_image] =>[orig_patent_app_number] => 465929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3936666 [patent_doc_number] => 05871943 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Immunoassay comprising a truncated pneumococcal surface protein A (PspA)' [patent_app_type] => 1 [patent_app_number] => 8/468718 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 7411 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/871/05871943.pdf [firstpage_image] =>[orig_patent_app_number] => 468718 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3781469 [patent_doc_number] => 05840317 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Composition comprising tumor cell lines containing GD2 ganglioside GM2 ganglioside, M-TAA, and either M-urinary antigen or M-fetal antigen' [patent_app_type] => 1 [patent_app_number] => 8/468029 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8448 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840317.pdf [firstpage_image] =>[orig_patent_app_number] => 468029 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3737949 [patent_doc_number] => 05753463 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Structural gene of pneumococcal protein' [patent_app_type] => 1 [patent_app_number] => 8/469434 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 10 [patent_no_of_words] => 7418 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753463.pdf [firstpage_image] =>[orig_patent_app_number] => 469434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3893998 [patent_doc_number] => 05750395 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-12 [patent_title] => 'DNA encoding MAGE-1 C-terminal cytotoxic t lymphocyte immunogenic peptides' [patent_app_type] => 1 [patent_app_number] => 8/465167 [patent_app_country] => US [patent_app_date] => 1995-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 9 [patent_no_of_words] => 13863 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/750/05750395.pdf [firstpage_image] =>[orig_patent_app_number] => 465167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795772 [patent_doc_number] => 05827671 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-27 [patent_title] => 'Antibodies raised against proteins of Leishmania which are expressed at an increased level in the amastigote form' [patent_app_type] => 1 [patent_app_number] => 8/460555 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 14 [patent_no_of_words] => 5827 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/827/05827671.pdf [firstpage_image] =>[orig_patent_app_number] => 460555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795142 [patent_doc_number] => 05780591 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Protein of Leishmania which is expressed at an increased level in the amastigote form' [patent_app_type] => 1 [patent_app_number] => 8/460746 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 12 [patent_no_of_words] => 5825 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780591.pdf [firstpage_image] =>[orig_patent_app_number] => 460746 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3993512 [patent_doc_number] => 05858368 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein' [patent_app_type] => 1 [patent_app_number] => 8/453848 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 6 [patent_no_of_words] => 20055 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/858/05858368.pdf [firstpage_image] =>[orig_patent_app_number] => 453848 [rel_patent_id] =>[rel_patent_doc_number] =>)